Santosh Mahil Takes the Helm at Sekhmet Pharmaventures

Company - People | Jun 04, 2025 | EIN

A PAG-led consortium has appointed Santosh Kumar Mahil as the new Managing Director and Chief Executive Officer of Sekhmet Pharmaventures, aiming to lead the development of future active pharmaceutical ingredient companies. Mahil's extensive experience, including roles at Shilpa Pharma Life Sciences, Lupin, USV, and Unichem, positions him as a key figure to advance the enterprise. PAG's Nikhil Srivastava emphasized Mahil's transformative capabilities to turn promising businesses into industry leaders.

Sectors

Pharmaceuticals
Private Equity

Geography

Global – The article references a global executive hire with experience in multinational companies, indicating a broad geographic relevance.

Industry

Pharmaceuticals – The article is centered around API companies and is aimed at nurturing the growth of pharmaceutical ventures.
Private Equity – The appointment of a CEO and the involvement of a PAG-led consortium indicates active private equity participation.

Financials

Participants

Name	Role	Type	Description
Santosh Kumar Mahil	Managing Director & CEO	Person	Appointed as the new MD & CEO of Sekhmet Pharmaventures, with an extensive track record in the industry.
Sekhmet Pharmaventures	Target Company	Company	An investment platform focused on growing the next generation of API companies.
PAG	Private Equity Consortium Leader	Company	A private equity firm leading the consortium that appointed the new MD & CEO.
Shilpa Pharma Life Sciences	Former Company of New CEO	Company	Previous employer of Santosh Mahil, where he served as CEO prior to his new appointment.
Lupin	Former Employer	Company	A previous employer of Santosh Mahil in the pharmaceutical industry.
USV	Former Employer	Company	A previous employer of Santosh Mahil in the pharmaceutical industry.
Unichem	Former Employer	Company	A previous employer of Santosh Mahil in the pharmaceutical industry.